PRC2-mediated repression of SMARCA2 predicts EZH2 inhibitor activity in SWI/SNF mutant tumors.
about
PRC2-mediated repression of SMARCA2 predicts EZH2 inhibitor activity in SWI/SNF mutant tumors.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh
2017年學術文章
@zh-hant
name
PRC2-mediated repression of SM ...... vity in SWI/SNF mutant tumors.
@en
PRC2-mediated repression of SM ...... vity in SWI/SNF mutant tumors.
@nl
type
label
PRC2-mediated repression of SM ...... vity in SWI/SNF mutant tumors.
@en
PRC2-mediated repression of SM ...... vity in SWI/SNF mutant tumors.
@nl
prefLabel
PRC2-mediated repression of SM ...... vity in SWI/SNF mutant tumors.
@en
PRC2-mediated repression of SM ...... vity in SWI/SNF mutant tumors.
@nl
P2093
P2860
P356
P1476
PRC2-mediated repression of SM ...... vity in SWI/SNF mutant tumors.
@en
P2093
Benjamin Haley
Bruno Alicke
Robert L Yauch
Russell Bainer
Thomas Januario
Tunde Smith
Xiaofen Ye
P2860
P304
12249-12254
P356
10.1073/PNAS.1703966114
P407
P577
2017-10-30T00:00:00Z